Upgrade to SI Premium - Free Trial

Piper Jaffray Defends Alexion Pharmaceuticals (ALXN)

August 30, 2019 10:44 AM
Piper Jaffray analyst Chris Raymond reiterated an Overweight rating and $180.00 price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles